Direct and indirect pathways of basal ganglia: a critical reappraisal
暂无分享,去创建一个
[1] T. Pasik,et al. A Golgi study of neuronal types in the neostriatum of monkeys , 1976, Brain Research.
[2] J. Bouyer,et al. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum , 1984, Brain Research.
[3] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[4] A. D. Smith,et al. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium‐size spiny neurons in the rat neostriatum , 1988, The Journal of comparative neurology.
[5] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[6] C. Wilson,et al. Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. , 1989, Journal of neurophysiology.
[7] M. Delong,et al. Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.
[8] H. Bergman,et al. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.
[9] C. Gerfen,et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.
[10] C. Wilson,et al. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[11] T. Aziz,et al. Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate , 1991, Movement disorders : official journal of the Movement Disorder Society.
[12] S. Sesack,et al. Cellular basis for interactions between catecholaminergic afferents and neurons containing leu‐enkephalin‐like immunoreactivity in rat caudate‐putamen nuclei , 1992, Journal of neuroscience research.
[13] P. Calabresi,et al. Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum , 1992, Neuroscience Letters.
[14] P. Calabresi,et al. Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] J. Bolam,et al. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat , 1992, Neuroscience.
[16] D. Lovinger,et al. Short- and long-term synaptic depression in rat neostriatum. , 1993, Journal of neurophysiology.
[17] Charles J. Wilson,et al. Striatal interneurones: chemical, physiological and morphological characterization , 1995, Trends in Neurosciences.
[18] D. Pinault,et al. Single striatofugal axons arborizing in both pallidal segments and in the substantia nigra in primates , 1995, Brain Research.
[19] A. Lang,et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. , 1997, Advances in neurology.
[20] P. Calabresi,et al. A Critical Role of the Nitric Oxide/cGMP Pathway in Corticostriatal Long-Term Depression , 1999, The Journal of Neuroscience.
[21] P. Greengard,et al. Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity , 2000, The Journal of Neuroscience.
[22] J. Dostrovsky,et al. Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. , 2001, Journal of neurophysiology.
[23] D. Lovinger,et al. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum , 2002, Nature Neuroscience.
[24] P. Calabresi,et al. Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission , 2002, The Journal of Neuroscience.
[25] David M. Lovinger,et al. It could be habit forming: drugs of abuse and striatal synaptic plasticity , 2003, Trends in Neurosciences.
[26] Klaus Mewes,et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease , 2003, Annals of neurology.
[27] P. Calabresi,et al. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism , 2003, Journal of neurochemistry.
[28] D. Lovinger,et al. Disruption of Endocannabinoid Release and Striatal Long-Term Depression by Postsynaptic Blockade of Endocannabinoid Membrane Transport , 2004, The Journal of Neuroscience.
[29] G. Bernardi,et al. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? , 2005, Trends in pharmacological sciences.
[30] A. Parent,et al. The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] I Litvan,et al. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. , 2005, Brain : a journal of neurology.
[32] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[33] Rui M. Costa,et al. Rapid Alterations in Corticostriatal Ensemble Coordination during Acute Dopamine-Dependent Motor Dysfunction , 2006, Neuron.
[34] Kae Nakamura,et al. Basal ganglia orient eyes to reward. , 2006, Journal of neurophysiology.
[35] Erwan Bezard,et al. Phenotype of Striatofugal Medium Spiny Neurons in Parkinsonian and Dyskinetic Nonhuman Primates: A Call for a Reappraisal of the Functional Organization of the Basal Ganglia , 2006, The Journal of Neuroscience.
[36] D. Lovinger,et al. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Fahn,et al. Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint , 1999, Movement disorders : official journal of the Movement Disorder Society.
[38] A. Reiner,et al. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling , 2006, Journal of Chemical Neuroanatomy.
[39] Henry H. Yin,et al. Dopaminergic Control of Corticostriatal Long-Term Synaptic Depression in Medium Spiny Neurons Is Mediated by Cholinergic Interneurons , 2006, Neuron.
[40] A. Sampson,et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models , 2006, Nature Neuroscience.
[41] Robert C. Malenka,et al. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models , 2007, Nature.
[42] D. Lovinger,et al. Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step , 2007, Proceedings of the National Academy of Sciences.
[43] Paolo Calabresi,et al. Dopamine-mediated regulation of corticostriatal synaptic plasticity , 2007, Trends in Neurosciences.
[44] H. Bergman,et al. Pathological synchronization in Parkinson's disease: networks, models and treatments , 2007, Trends in Neurosciences.
[45] Joshua L Plotkin,et al. Differential Excitability and Modulation of Striatal Medium Spiny Neuron Dendrites , 2008, The Journal of Neuroscience.
[46] Max Kleiman-Weiner,et al. Differential electrophysiological properties of dopamine D1 and D2 receptor‐containing striatal medium‐sized spiny neurons , 2008, The European journal of neuroscience.
[47] Valeria Della-Maggiore,et al. Functional integration across a gradient of corticostriatal channels controls UP state transitions in the dorsal striatum , 2008, Proceedings of the National Academy of Sciences.
[48] P. Calabresi,et al. The endocannabinoid system in Parkinson's disease. , 2008, Current pharmaceutical design.
[49] D. Surmeier,et al. Dichotomous Anatomical Properties of Adult Striatal Medium Spiny Neurons , 2008, The Journal of Neuroscience.
[50] P. Greengard,et al. Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity , 2008, Science.
[51] E. Nestler,et al. Neurotrophic factors and structural plasticity in addiction , 2009, Neuropharmacology.
[52] S. Schiffmann,et al. D2R striatopallidal neurons inhibit both locomotor and drug reward processes , 2009, Nature Neuroscience.
[53] Erwan Bezard,et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders , 2009, The Lancet Neurology.
[54] D. Lovinger,et al. Endocannabinoid‐dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity , 2009, The European journal of neuroscience.
[55] B. O'dowd,et al. Calcium signaling cascade links dopamine D1–D2 receptor heteromer to striatal BDNF production and neuronal growth , 2009, Proceedings of the National Academy of Sciences.
[56] G. Fisone,et al. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice , 2009, Trends in Neurosciences.
[57] N. Volkow,et al. Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.
[58] Neuroscience: Brain's traffic lights , 2010, Nature.
[59] J. Roiser,et al. Reward and Punishment Processing in Depression , 2010, Biological Psychiatry.
[60] S. Nakanishi,et al. Distinct Roles of Synaptic Transmission in Direct and Indirect Striatal Pathways to Reward and Aversive Behavior , 2010, Neuron.
[61] P. Krack,et al. Deep brain stimulation: from neurology to psychiatry? , 2010, Trends in Neurosciences.
[62] S. Vincent. Nitric oxide neurons and neurotransmission , 2010, Progress in Neurobiology.
[63] O. Rascol,et al. Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson’s Disease , 2010, CNS drugs.
[64] G. Lynch,et al. Presynaptic BDNF Promotes Postsynaptic Long-Term Potentiation in the Dorsal Striatum , 2010, The Journal of Neuroscience.
[65] Xin Jin,et al. Start/stop signals emerge in nigrostriatal circuits during sequence learning , 2010, Nature.
[66] Paul Greengard,et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors , 2010, Proceedings of the National Academy of Sciences.
[67] P. Calabresi,et al. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap , 2010, The Lancet Neurology.
[68] David M. Lovinger,et al. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum , 2010, Neuropharmacology.
[69] H. Bergman,et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease , 2010, Nature Reviews Neuroscience.
[70] Anatol C. Kreitzer,et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry , 2010, Nature.
[71] P. Calabresi,et al. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. , 2011, Brain : a journal of neurology.
[72] B. Roth,et al. Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization , 2010, Nature Neuroscience.
[73] P. Calabresi,et al. The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease , 2011, The Journal of Neuroscience.
[74] D. Sibley,et al. Dopamine D2 Receptor Overexpression Alters Behavior and Physiology in Drd2-EGFP Mice , 2011, The Journal of Neuroscience.
[75] Laurent Venance,et al. Spike-timing dependent plasticity in striatal interneurons , 2011, Neuropharmacology.
[76] Kuei Yuan Tseng,et al. Nitric Oxide–Soluble Guanylyl Cyclase–Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease? , 2011, Front. Syst. Neurosci..
[77] P. Calabresi,et al. Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease , 2011, The Journal of Neuroscience.
[78] A. Pisani,et al. Homeostatic changes of the endocannabinoid system in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[79] C. Gerfen,et al. Modulation of striatal projection systems by dopamine. , 2011, Annual review of neuroscience.
[80] Yvette E. Fisher,et al. Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's Disease , 2011, The Journal of Neuroscience.
[81] E. Bézard,et al. Molecular mechanisms of l-DOPA-induced dyskinesia. , 2011, International review of neurobiology.
[82] Antonio Daniele,et al. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation , 2012, The Lancet Neurology.
[83] P. Calabresi,et al. Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease , 2012, The Journal of Neuroscience.
[84] S. Fox,et al. Drug treatments for the neuropsychiatric complications of Parkinson’s disease , 2012, Expert review of neurotherapeutics.
[85] Anatol C. Kreitzer,et al. A Comparison of Striatal-Dependent Behaviors in Wild-Type and Hemizygous Drd1a and Drd2 BAC Transgenic Mice , 2012, The Journal of Neuroscience.
[86] Joshua L. Plotkin,et al. Strain-Specific Regulation of Striatal Phenotype in Drd2-eGFP BAC Transgenic Mice , 2012, The Journal of Neuroscience.
[87] Anatol C. Kreitzer,et al. Distinct roles for direct and indirect pathway striatal neurons in reinforcement , 2012, Nature Neuroscience.
[88] T. Tkatch,et al. SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance , 2012, Nature Neuroscience.
[89] L. Wilbrecht,et al. Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value , 2012, Nature Neuroscience.
[90] Brian N. Mathur,et al. Endocannabinoid–Dopamine Interactions in Striatal Synaptic Plasticity , 2012, Front. Pharmacol..
[91] L. Riquelme,et al. Striatal NMDA receptors gate cortico-pallidal synchronization in a rat model of Parkinson's disease , 2012, Neurobiology of Disease.
[92] Ian R. Wickersham,et al. Convergent cortical innervation of striatal projection neurons , 2013, Nature Neuroscience.
[93] Steven S. Vogel,et al. Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation , 2013, Nature.
[94] Anatol C. Kreitzer,et al. Control of Basal Ganglia Output by Direct and Indirect Pathway Projection Neurons , 2013, The Journal of Neuroscience.
[95] P. Calabresi,et al. Ischemic-LTP in Striatal Spiny Neurons of both Direct and Indirect Pathway Requires the Activation of D1-Like Receptors and NO/Soluble Guanylate Cyclase/cGMP Transmission , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[96] G. Deuschl,et al. Neurostimulation for Parkinson's disease with early motor complications. , 2013, The New England journal of medicine.
[97] L. Bour,et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial , 2013, The Lancet Neurology.
[98] H. Moore,et al. Dopamine D2 Receptors Regulate the Anatomical and Functional Balance of Basal Ganglia Circuitry , 2014, Neuron.
[99] John P. Walsh,et al. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease , 2014, Neurobiology of Disease.
[100] B. O'dowd,et al. Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance , 2014, Neuropsychopharmacology.
[101] David A. Lewis,et al. Implications for Parkinson ' s Disease , 2022 .